Patents by Inventor Woo Seon HWANG

Woo Seon HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR INHIBITING RELEASE OF NEUROTRANSMITTERS
    Publication number: 20220142908
    Abstract: The present disclosure relates to a composition for inhibiting neurotransmitter secretion by inhibiting membrane potential generation of the nerve. The composition of the present disclosure has a synergistic effect related to inhibition of SNARE complex formation, and thereby, it can prevent active secretion of neurotransmitters, and thus can reduce muscle contraction to improve skin wrinkles.
    Type: Application
    Filed: February 20, 2020
    Publication date: May 12, 2022
    Applicant: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Woo-Seon HWANG, Yun-Sun KIM, Mu-Hyun JIN, Nae-Gyu KANG
  • Anti-aging transgenic Caenorhabditis elegans
    Patent number: 11013221
    Abstract: The present invention relates to: a transgenic Caenorhabditis elegans in which a glutamine tRNA 5? terminus-derived fragment (Gln 5?-tsRNA) is overexpressed; a preparation method therefor; and a method for screening for aging-associated factors by using the transgenic Caenorhabditis elegans. A transgenic Caenorhabditis elegans model provided in the present invention is an animal model in which Gln 5?-tsRNA is overexpressed such that aging is inhibited. When the model of the present invention is used, anti-aging mechanisms can be easily investigated, thereby significantly contributing to various research fields such as that of developing new anti-aging drugs and screening for age-inducing materials.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: May 25, 2021
    Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION, INSTITUTE FOR BASIC SCIENCE, DAEGU GYEONGBUK INSTITUTE OF SCIENCE
    Inventors: Hong Gil Nam, Gyoo Yeol Jung, Seung Jae Lee, Woo Seon Hwang, Gi Won Shin, Mi Hwa Seo
  • ANTI-AGING TRANSGENIC CAENORHABDITIS ELEGANS
    Publication number: 20190200589
    Abstract: The present invention relates to: a transgenic Caenorhabditis elegans in which a glutamine tRNA 5? terminus-derived fragment (Gln 5?-tsRNA) is overexpressed; a preparation method therefor; and a method for screening for aging-associated factors by using the transgenic Caenorhabditis elegans. A transgenic Caenorhabditis elegans model provided in the present invention is an animal model in which Gln 5?-tsRNA is overexpressed such that aging is inhibited. When the model of the present invention is used, anti-aging mechanisms can be easily investigated, thereby significantly contributing to various research fields such as that of developing new anti-aging drugs and screening for age-inducing materials.
    Type: Application
    Filed: April 21, 2017
    Publication date: July 4, 2019
    Applicants: Postech Academy-Industry Foundation, Institute for Basic Science, Daegu Gyeongbuk Institute of Science
    Inventors: Hong Gil NAM, Gyoo Yeol JUNG, Seung Jae LEE, Woo Seon HWANG, Gi Won SHIN, Mi Hwa SEO